Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

CureVac and Yale Team Up for mRNA-Based Lung Therapies

Tubingen, Germany-based CureVac entered a collaboration research agreement with Yale University to focus on lung therapies.

Read More »

AbbVie Raises 2019 Profit Target

Despite concerns about potential competition from recently approved and available European biosimilars to Humira, AbbVie was able to stave off some of the losses expected during Q2 2019.

Read More »

Sanofi signs U.S. rights deal with Roche for flu treatment Tamiflu

French drugs and healthcare group Sanofi signed a rights deal with Roche for Tamiflu in the United States.

Read More »

Durect and Gilead Collaborate on HIV Therapy

A collaboration and license deal was inked with Gilead Sciences Inc. to develop and market a long-acting injectable HIV therapy using Durect Corp.’s SABER technology.

Read More »

Bayer sells Dr. Scholl’s footcare brand to Yellow Wood Partners

Germany’s Bayer signed a deal to sell the company’s Dr. Scholl’s footcare brand to U.S. private investment firm Yellow Wood Partners for $585 million.

Read More »

Genentech Strikes Three Drug Discovery Deals

In a deal-making morning for South San Francisco-based Genentech, the Roche subsidiary struck three separate transactions with small companies to boost drug development.

Read More »

AbbVie Makes ‘Transformational’ Move with $63 Billion Acquisition of Allergan

Illinois-based AbbVie announced that the company will acquire Ireland-based Allergan for $63 billion in a cash and stock deal.

Read More »

GSK offers concessions to address EU concerns over Pfizer deal

GlaxoSmithKline offered concessions to address EU antitrust concerns over the planned joint venture with Pfizer’s consumer health business, the European Commission said.

Read More »

AbCellera and Gilead Forge Infectious Disease Pact

Vancouver-based AbCellera and Gilead Sciences forged a collaborative agreement to discover and develop ultra-rare antibodies that can be used in the treatment of a number of infectious diseases.

Read More »

Germany’s Stada buys six of GSK’s consumer brands, eyes further deals

Stada said on Friday the private equity-backed company would buy six consumer healthcare products from British GlaxoSmithKline to bolster the generic drugmaker’s presence in Europe.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

August 2019 Focus: AI, AR/VR, Top 200 Medicines, Lions Health Takeaways, and more!

Subscribe

Ad Right Bottom